<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Many effective anticancer therapies against <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> have been developed, but chemoresistance and recurrence are still inevitable problems and their counter measures are urgently needed </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cells have been indicated to play a pivotal role in chemoresistance and recurrence and have gained attention as a novel target </plain></SENT>
<SENT sid="2" pm="."><plain>On the other hand, both aberrant hyper- and hypomethylation have been shown to be involved in <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> and the simultaneous amendment is indispensable </plain></SENT>
<SENT sid="3" pm="."><plain>Cyclooxygenase-2 (COX-2) has already been reported to play an important role in <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Our latest study indicates that COX-2 inhibitors remedy aberrant methylation and beat <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stemness, suggesting that COX-2 inhibitors hold great promise for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> prevention and therapy </plain></SENT>
</text></document>